Physician profile
Harvey Arthur Nurick
NPI 1720041486
$1,760.10
in general payments reported to CMS, 2019-2025
21 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.04 · 2020: $96.08 · 2021: $250 · 2022: $562 · 2023: $314 · 2024: $108 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $556.44 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Silk Road Medical, INC. | $191.11 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cardiovascular Systems INC. | $152.23 | 2020-2021 | |
| Angiodynamics, INC. | $147.42 | 2025 | Auryon Laser System 100-120 Vac |
| Elucent Medical | $137.51 | 2025 | |
| Aroa Biosurgery Incorporated | $118.75 | 2022-2024 | |
| Lemaitre Vascular, INC. | $85.05 | 2021 | |
| Smith+Nephew, INC. | $70.67 | 2025 | Stravix |
| Medtronic, INC. | $52.24 | 2021-2025 | Progrip |
| Bard Peripheral Vascular, INC. | $40.58 | 2021-2022 | |
| Tela Bio, INC. | $37.27 | 2024 | Ovitex 2s |
| Trevena, INC. | $32.69 | 2021 | |
| Imperative Care, INC | $24.85 | 2025 | Symphony Catheter |
| Abbvie INC. | $22.96 | 2020 | |
| Tactile Systems Technology INC | $21.74 | 2025 | Nimbl, Flexitouch Plus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $20.98 | 2023 | Zenith |
| Baxter Healthcare | $18.28 | 2023 | Preveleak |
| Galvanize Therapeutics, INC | $15.29 | 2024 | Aliya System |
| Covidien LP | $14.04 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Nurick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.